Related Articles
miR‑494 inhibits cancer‑initiating cell phenotypes and reverses resistance to lapatinib by downregulating FGFR2 in HER2‑positive gastric cancer
Upregulation of miR-137 reverses sorafenib resistance and cancer-initiating cell phenotypes by degrading ANT2 in hepatocellular carcinoma
miR-206 inhibits metastasis-relevant traits by degrading MRTF-A in anaplastic thyroid cancer
MicroRNA-206 inhibits the viability and migration of human lung adenocarcinoma cells partly by targeting MET
Downregulation of microRNA-206 suppresses clear cell renal carcinoma proliferation and invasion by targeting vascular endothelial growth factor A Retraction in /10.3892/or.2024.8717